Nearly 3 years after Breakthrough T1D joined forces with Civica, a non-profit pharmaceutical company, its first insulin is now available for purchase at pharmacies across the country.

We worked with our partners at Civica to answer some of the most common questions you may have about this insulin and where to get it.

What is it called?

Civica insulin glargine-yfgn. It will have a “CalRx” label in California.

What insulin is for sale?

Civica insulin glargine-yfgn is a long-acting insulin interchangeable with Lantus.

Where can I get it?

Broad availability is expected at U.S. pharmacies as production increases. Ask your pharmacist.

How do I get it?

If you have health insurance:

  • Check your plan’s formulary to ensure Civica insulin glargine-yfgn is listed. If so, just ask your pharmacy to order it when you take in (or refill) your prescription.

If you are paying cash:

  • Cash-paying patients can buy Civica insulin glargine-yfgn at the manufacturer’s recommended price, without any coupons or patient assistance program needed. Just ask your pharmacy to order it when you take in (or refill) your prescription.

For Californians:

  • Civica’s insulin glargine-yfgn is available under the CalRx brand in California pharmacies.

How much does it cost?

Max recommended price: $55 per box of five pens. Your cost may be lower depending on insurance. This is the lowest list price for long-acting insulin, without hidden rebates or markups.

Do I need a prescription?

Yes. If you already have a prescription for insulin glargine (e.g., Lantus), you do not need a new one because Civica insulin glargine-yfgn is interchangeable. Confirm with your provider and pharmacist.

Can I buy a single pen?

No. Pens are sold in boxes of five pre-filled pens.

Is it covered by insurance?

Yes, but you don’t need insurance to buy it. Out-of-pocket costs could be as low as $0 depending on your plan.

You can learn more about Civica insulin at CivicaInsulin.org.